| 英文别名 |
Docosanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-;N-behenoyl-D-erythro-sphingosine;C22-Ceramide;C22 Cer;N-(docosanoyl)-sphing-4-enine;N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]docosanamide;C22 Ceramide;Ceramide (d18:1/22:0);CS-0784677;N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]docosanamide;N-docosanoylsphing-4-enine;LMSP02010008;N-(docosanoyl)-ceramide;AKOS040755907;C22 Ceramide (d18:1/22:0), N-behenoyl-D-erythro-sphingosine, powder;N-(docosanoyl)sphing-4-enine;N-(docosanoyl)ceramide;N-Behenoyl-D-erythro-sphingosine;C22 Ceramide (d18:1/22:0);N-(docosanoyl) sphingosine;Q27140219;Docosanamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-;869501-30-4;N-[(E, 2S, 3R)-1, 3-dihydroxyoctadec-4-en-2-yl]docosanamide;KEPQASGDXIEOIL-GLQCRSEXSA-N;N-[1.3-dihydroxyoctadec-4-en-2-yl]docosanamide;N-behenoylsphingosine;BP-28821;27888-44-4;Ceramide d40:1;Cer(d18:1/22:0);CHEBI:72966;Docosanamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-;N-docosanoylsphingosine;HY-154831;N-behenoyl-sphingosine;N-[(2s,3r,4e)-1,3-dihydroxy-4-octadecen-2-yl]docosanamide;QMP7UK77DD;DB-231026 |
微信公众号
客服
